Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Edotreotide"'
Publikováno v:
Cancer Research. 81:CT254-CT254
Background Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) make up 75% of all NETs and are often diagnosed at an advanced state with only limited treatment options. Current standard therapies include somatostatin (SST) analogues and targeted
Autor:
Provost, Claire
La Tomographie par Emission de Positons (TEP) est une modalité d’imagerie médicale en pleine expansion depuis une quinzaine d’années. En oncologie, la TEP au 18F-fluorodésoxyglucose (FDG) est devenue un outil essentiel pour la prise en charge
Externí odkaz:
http://www.theses.fr/2018SACLS052/document
Publikováno v:
Annals of Oncology. 29:viii478
Autor:
David L. Bushnell, Al B. Benson, Katherine A. Kacena, Ashley B. Grossman, Eric Van Cutsem, Lowell Anthony, M. Sue O'Dorisio, Mary Connolly, Rodney J. Hicks, Thomas M. O'Dorisio, Kjell Öberg, Stanislas Pauwels, Yong Li, Jean Louis Baulieu, Françoise Borson-Chazot, Hakim Bouterfa, Yusuf Menda, Norman LaFrance
Publikováno v:
Journal of Clinical Oncology. 28:1652-1659
Purpose Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea and flushing, can be debilitating and occasionally life-threatening. Although symptom relief is available with octreotide, the disease eventually becomes refract
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 81:379-380
Autor:
Baier, Nina
Neuroendocrine tumors are a heterogeneous group of relatively rare malignancies. The value of FDG positron emission tomography for the assessment of neuroendocrine tumors is limited. Preliminary studies indicate that 18F-DOPA and various somatostatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31cb10e7eadc48c8d598e9b8aa0733be